For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
Compound-specific reconstitution examples Different research peptides ship in different vial sizes and have different solubility quirks
Jzwiak M, Bauer M, Kamysz W, Kleczkowska P
Qiu S, Yang W-Z, Shi X-J, Yao C-L, Yang M, Liu X, et al
If your Part D plan does not cover B12 shots, you may request consideration under the plans utilization management program
Oral protocols Results from oral use are less noticeable and take longer to start than those from injections